Composition for treating irritable bowel syndrome
AssigneeKing Faisal University
InventorsHairul Islam Mohamed Ibrahim, Ashraf Yassin Zaky Khalifa
Life of this patent
Estimating the term…
Abstract
A composition for treating irritable bowel syndrome can include a mixture of Bacillus amyloliquefaciens, Enterococcus faecium, and Vitamin D (Calciferol). The composition can be administered to a patient to treat irritable bowel syndrome or symptoms associated with irritable bowel syndrome. For example, the composition can be used to treat colitis. The composition can include about 1×106 to 1×1012 colony forming units (CFU) of Bacillus amyloliquefaciens and Enterococcus faecium per unit dose. In an embodiment, the composition can include at least 1 to 25 mg/L Vitamin-D.
Claims1
A composition for treating irritable bowel syndrome in a human comprising:
- a probiotic comprising 1×108 colony forming units of Bacillus amyloliquefaciens (BA) and 1×109 colony forming units of Enterococcus faecium (EF);
- from 0.5 uM-10 uM of Vitamin D;
- and
- a pharmaceutically acceptable carrier configured for administration to a human,
- wherein the composition has a pH of 3.6 to 6.1.
Dependencies are inferred from the claim text.